Finally, for IGF2BP1, the oncofetal IGF2 mRNA binding proteins (IGFBPs) are upregulated in various cancer entities and have been shown to possess a distinct conservation of highly oncogenic potential throughout a panel of five cancer-derived cell lines [51]. This evidence concerns the gene IGF2 and cancer.